Leave Your Message
products-news-banners02

FDF

Our self-developed drug has been approved for market by multiple countries, with over 30 ongoing research projects

    Thymalfasin for Injection
    con-1
    01

    Thymalfasin for Injection
    Immune System Modulation
    Thymopentin for Injection
    con-1
    02

    Thymopentin for Injection
    Immune System Modulation
    Trimetazidine Tablets
    con-1
    03

    Trimetazidine Tablets
    Cardiovascular
    Eptifibatide Injection
    con-1
    04

    Eptifibatide Injection
    Cardiovascular
    Sitagliptin and Metformin Hydrochloride Tablets (II)
    con-1
    05

    Sitagliptin and Metformin Hydrochloride Tablets (II)
    Diabetes Mellitus
    Disposable Injection Pen
    con-1
    06

    Disposable Injection Pen
    Medical Devices
    Glatiramer Injection
    con-1
    07

    Glatiramer Injection
    Immune System Modulation
    Liraglutide Injection
    con-1
    08

    Liraglutide Injection
    Diabetes Mellitus
    FirstPrev123NextLastTotal 3

    Product Pipeline

    R&D Projects Indications Status
    HY3000 Nasal Spray Prevention & treatment of COVID-19 Phase III
    HY3001 COVID-19 Peptide Vaccine Prevention of COVID-19 Preclinical
    HY3003 GLP-1R/GIPR/GCGR Triple Agonist Diabetes mellitus & Weight loss & MASH Preclinical
    Glatiramer Acetate Injection Multiple sclerosis Approved in US
    Cetrorelix Acetate for Injection Assisted reproduction Pending approval
    Teriparatide Injection Osteoporosis  Pending approval
    Carboprost Tromethamine Injection Postpartum hemorrhage Pending approval
    Semaglutide Injection Diabetes mellitus & Weight loss Phase III
    Abaloparatide Injection Osteoporosis FDF Process Validation
    Teriparatide Acetate for Injection Osteoporosis  FDF Process Validation
    Difelikefalin acetate Injection CKD-Pruritus FDF Process Validation
    Tirzepatide Injection Diabetes mellitus & Weight loss FDF Process Validation
    Linaclotide Capsules IBS-C and CIC FDF Process Validation
    Plecanatide Tablets IBS-C and CIC API Process Validation
    Etelcalcetide Hydrochloride Injection CKD-Econdary hyperparathyroidism API Process Validation
    Lanreotide Acetate Sustained-Release Injection Acromegaly API Process Validation
    Semaglutide Tablets Diabetes mellitus & Weight loss API Process Validation
    Sucrose Iron Hydroxide Chewable Tablets CKD-Related hyperphosphatemia R&D
    Ferric Carboxymaltose Injection Iron deficiency anemia R&D
    Pegcetacoplan Injection Geographic atrophy R&D